Literature DB >> 23813081

Discriminative validity of metabolic and workload measurements for identifying people with chronic fatigue syndrome.

Christopher R Snell1, Staci R Stevens, Todd E Davenport, J Mark Van Ness.   

Abstract

BACKGROUND: Reduced functional capacity and postexertion fatigue after physical activity are hallmark symptoms of chronic fatigue syndrome (CFS) and may even qualify for biomarker status. That these symptoms are often delayed may explain the equivocal results for clinical cardiopulmonary exercise testing in people with CFS. Test reproducibility in people who are healthy is well documented. Test reproducibility may not be achievable in people with CFS because of delayed symptoms.
OBJECTIVE: The objective of this study was to determine the discriminative validity of objective measurements obtained during cardiopulmonary exercise testing to distinguish participants with CFS from participants who did not have a disability but were sedentary.
DESIGN: A prospective cohort study was conducted.
METHODS: Gas exchange data, workloads, and related physiological parameters were compared in 51 participants with CFS and 10 control participants, all women, for 2 maximal exercise tests separated by 24 hours.
RESULTS: Multivariate analysis showed no significant differences between control participants and participants with CFS for test 1. However, for test 2, participants with CFS achieved significantly lower values for oxygen consumption and workload at peak exercise and at the ventilatory or anaerobic threshold. Follow-up classification analysis differentiated between groups with an overall accuracy of 95.1%. LIMITATIONS: Only individuals with CFS who were able to undergo exercise testing were included in this study. Individuals who were unable to meet the criteria for maximal effort during both tests, were unable to complete the 2-day protocol, or displayed overt cardiovascular abnormalities were excluded from the analysis.
CONCLUSIONS: The lack of any significant differences between groups for the first exercise test would appear to support a deconditioning hypothesis for CFS symptoms. However, the results from the second test indicated the presence of CFS-related postexertion fatigue. It might be concluded that a single exercise test is insufficient to reliably demonstrate functional impairment in people with CFS. A second test might be necessary to document the atypical recovery response and protracted fatigue possibly unique to CFS, which can severely limit productivity in the home and workplace.

Entities:  

Mesh:

Year:  2013        PMID: 23813081     DOI: 10.2522/ptj.20110368

Source DB:  PubMed          Journal:  Phys Ther        ISSN: 0031-9023


  35 in total

1.  Differences in ME and CFS Symptomology in Patients with Normal and Abnormal Exercise Test Results.

Authors:  Stephanie L McManimen; Leonard A Jason
Journal:  Int J Neurol Neurother       Date:  2017-03-21

Review 2.  Nutritional modulation of the intestinal microbiota; future opportunities for the prevention and treatment of neuroimmune and neuroinflammatory disease.

Authors:  Vincent C Lombardi; Kenny L De Meirleir; Krishnamurthy Subramanian; Sam M Nourani; Ruben K Dagda; Shannon L Delaney; András Palotás
Journal:  J Nutr Biochem       Date:  2018-04-19       Impact factor: 6.048

3.  Elevated Energy Production in Chronic Fatigue Syndrome Patients.

Authors:  Nick Lawson; Chung-Han Hsieh; Dana March; Xinnan Wang
Journal:  J Nat Sci       Date:  2016

Review 4.  Accurate diagnosis of myalgic encephalomyelitis and chronic fatigue syndrome based upon objective test methods for characteristic symptoms.

Authors:  Frank Nm Twisk
Journal:  World J Methodol       Date:  2015-06-26

5.  Variability in Symptoms Complicates Utility of Case Definitions.

Authors:  Stephanie L McManimen; Leonard A Jason; Yolonda J Williams
Journal:  Fatigue       Date:  2015-05-12

6.  Metabolic profiling indicates impaired pyruvate dehydrogenase function in myalgic encephalopathy/chronic fatigue syndrome.

Authors:  Øystein Fluge; Olav Mella; Ove Bruland; Kristin Risa; Sissel E Dyrstad; Kine Alme; Ingrid G Rekeland; Dipak Sapkota; Gro V Røsland; Alexander Fosså; Irini Ktoridou-Valen; Sigrid Lunde; Kari Sørland; Katarina Lien; Ingrid Herder; Hanne Thürmer; Merete E Gotaas; Katarzyna A Baranowska; Louis Mlj Bohnen; Christoph Schäfer; Adrian McCann; Kristian Sommerfelt; Lars Helgeland; Per M Ueland; Olav Dahl; Karl J Tronstad
Journal:  JCI Insight       Date:  2016-12-22

Review 7.  Mechanisms Explaining Muscle Fatigue and Muscle Pain in Patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): a Review of Recent Findings.

Authors:  Morris Gerwyn; Michael Maes
Journal:  Curr Rheumatol Rep       Date:  2017-01       Impact factor: 4.592

8.  A definition of recovery in myalgic encephalomyelitis and chronic fatigue syndrome should be based upon objective measures.

Authors:  Frank N M Twisk
Journal:  Qual Life Res       Date:  2014-06-17       Impact factor: 4.147

9.  Post-exertional malaise in veterans with gulf war illness.

Authors:  Jacob B Lindheimer; Aaron J Stegner; Glenn R Wylie; Jacquelyn C Klein-Adams; Neda E Almassi; Jacob V Ninneman; Stephanie M Van Riper; Ryan J Dougherty; Michael J Falvo; Dane B Cook
Journal:  Int J Psychophysiol       Date:  2019-11-28       Impact factor: 2.997

Review 10.  Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Diagnosis and Management in Young People: A Primer.

Authors:  Peter C Rowe; Rosemary A Underhill; Kenneth J Friedman; Alan Gurwitt; Marvin S Medow; Malcolm S Schwartz; Nigel Speight; Julian M Stewart; Rosamund Vallings; Katherine S Rowe
Journal:  Front Pediatr       Date:  2017-06-19       Impact factor: 3.418

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.